Endogenous opioid receptor

The endogenous opioid neurotransmitter system refers to a family of naturally occurring peptides—primarily β‐endorphins, enkephalins, dynorphins, and nociceptin/orphanin FQ—that act as ligands for specific G protein-coupled receptors known as opioid receptors. There are four main types of these receptors in humans: μ‐opioid receptor (MOPR), δ‐opioid receptor (DOPR), κ‐opioid receptor (KOPR), and nociceptin/orphanin FQ peptide receptor (NOPR). These receptors are widely distributed throughout the central nervous system as well as peripheral tissues including the lungs, heart, kidney, gastrointestinal tract, pancreas, neuroendocrine organs like the pituitary gland and adrenals, immune cells such as leukocytes—and play critical roles in modulating pain perception ("analgesia"), autonomic functions like breathing and heart rate control, immune responses including inflammation modulation, gastrointestinal motility regulation, learning/memory processes and emotional states[1][6]. Opioids—both endogenous peptides and exogenously administered drugs—exert their effects by binding to these GPCRs. This typically leads to inhibition of neuronal activity via reduced cAMP production or direct ion channel modulation. The complexity of this signaling underlies both therapeutic benefits such as analgesia but also adverse effects including tolerance development/addiction risk with chronic exposure to exogenous opioids[1]. Note on correctness: The term "Endogenous opioid neurotransmitter system" is not a canonical name for a single molecular target but rather describes an entire physiological network comprising multiple peptide ligands and their corresponding GPCR targets. For structured data purposes focused on drug targeting or molecular pharmacology it is more accurate to refer specifically to one of the individual opioid receptors ("μ-opioid receptor", "δ-opioid receptor", etc.) rather than this broad collective term[1].

Other names

Endogenous opioid systemOpioid neurotransmitter systemOpioid receptorsEndogenous opioids

Agonism or antagonism at μ-opioid receptor (MOPR), δ-opioid receptor (DOPR), κ-opioid receptor (KOPR), or nociceptin/orphanin FQ peptide receptor (NOPR) to modulate neurotransmission and cellular signaling[1].